Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
featured
Published in Cardiology and
2 other channels

Journal Scan / Research · September 28, 2017

Once-Weekly Exenatide Does Not Influence Cardiovascular Outcomes in Type 2 Diabetes

The New England Journal of Medicine

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Richard Pratley MD

The New England Journal of Medicine
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
N. Engl. J. Med 2017 Sep 14;[EPub Ahead of Print], RR Holman, MA Bethel, RJ Mentz, VP Thompson, Y Lokhnygina, JB Buse, JC Chan, J Choi, SM Gustavson, N Iqbal, AP Maggioni, SP Marso, P Öhman, NJ Pagidipati, N Poulter, A Ramachandran, B Zinman, AF Hernandez

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated